Reports for APO-TERAZOSIN
Brand name
APO-TERAZOSIN
Company Name
APOTEX INC
|
Drug Identification Number
02234503 |
Ingredients
TERAZOSIN |
Ingredient Strength
2 MG |
ATC Code
G04CA |
ATC Descriptor
DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
APO-TERAZOSIN | 100 BTL | Resolved | 2018-02-01 | 2018-08-20 | 37986 |
APO-TERAZOSIN | 100 BTL | Resolved | 2018-10-19 | 2018-12-27 | 65008 |
APO-TERAZOSIN | 100 BTL | Resolved | 2023-06-16 | 2024-04-02 | 195253 |
APO-TERAZOSIN | 100 BTL | Resolved | 2024-04-26 | 2024-05-10 | 226330 |
Showing 1 to 4 of 4
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
APO-TERAZOSIN | 500 BTL | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
Showing 1 to 1 of 1